Loading...
S-133639
Response Deadline
Jun 30, 2026, 11:00 PM(MDT)49 days
Eligibility
Contract Type
Special Notice
Peptoid-based chelating ligands offer a tunable platform for capturing and holding specific metal ions with high selectivity while resisting breakdown under physiological conditions. The technology combines structural flexibility with strong binding performance, which creates a practical path for applications where existing chelators fall short, including difficult metal removal in biological, environmental and separation settings.
How it Works
Peptoid-Based Chelating Ligands uses cyclic peptoid scaffolds, which are peptoid chains closed into ring structures and decorated with side chains chosen for metal binding. By changing the ring size, side-chain chemistry and spacing between binding groups, the ligand can be adjusted to favor certain hard metal ions, especially actinides and lanthanides.
Technical Description
Peptoids differ from peptides because their side chains attach to nitrogen rather than to carbon, which makes them more resistant to hydrolysis under physiological conditions. That stability matters because many conventional chelators can lose activity in the body or in harsh process streams, while peptoid-based structures are designed to remain intact long enough to bind and hold the target metal.
The invention describes cyclic peptoid ligands that can be built from linear peptoids and then cyclized, with the binding profile tuned through functional groups such as catecholates, phosphonates, amines, guanidinium groups, phosphoramidates, N-hydroxypyridones and CMPO-like groups. Linker length, hydrophobicity, hydrophilicity and the number of coordinating groups can be adjusted to improve selectivity for specific ions and to support either tight retention for removal or controlled release after capture.
Advantages
Market Applications
TRL 4
US Patent Nos. 11,254,708; 11,859,018
LA-UR-26-23913
LANL Tech Partnerships: Unlock the Innovative Potential
Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products.
LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov.
Note: This is not a call for external services for the development of this technology.
https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology
m.lanl.gov/tech-search
Caleb Ledgerwood
Lindsay Augustyn
DEPARTMENT OF ENERGY
DEPARTMENT OF ENERGY
TRIAD - DOE CONTRACTOR
TRIAD - DOE CONTRACTOR
505 King Ave
Columbus, OH, 43201
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
PSC
ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE
Set-Aside
No Set aside used